中文 | English
Return
Total: 36 , 1/4
Show Home Prev Next End page: GO
Author:( Lirong YIN)

1.Effects of FABP-5 gene silencing on the biological characteristics of the cervical carcinoma cell line SiHa

Fengzhen CHEN ; Lirong YIN

Chinese Journal of Tissue Engineering Research 2016;20(15):2218-2224

2.Effects of combined treatment using umbilical cord blood mesenchymal stem cell transplantation and paclitaxel on proliferation, apoptosis, and invasion of A2780 ovarian cancer cells

Fengzhen CHEN ; Lirong YIN

Chinese Journal of Tissue Engineering Research 2016;20(20):2927-2932

3.The Changes of Serum Estradiol and TNF-Alpha Levels in Endometriosis Patients with Pelvic Pain

Zhiying QI ; Lirong YIN

Tianjin Medical Journal 2014;(2):138-140

4.The relationship between oxidative stress and estrogen receptor levels in ectopic endometrium and pelvic pain

Ruimeng GUO ; Lirong YIN

Tianjin Medical Journal 2016;44(1):88-90,130

5.Association between hTERT Gene Amplification and High-Risk HPV Infection in Cervical Lesions

Honglin LI ; Lirong YIN ; Junjie SUN

Tianjin Medical Journal 2014;(2):127-130

6.Exploration of SHDC in public hospital investor management

Jinghui LI ; Lirong ZHUGE ; Yuanfang YIN

Chinese Journal of Hospital Administration 2015;(8):585-587

7.E6/E7 mRNA expression level in cervical lesions with high-risk HPV infection

Shenjia LIU ; Lirong YIN ; Honglin LI

Tianjin Medical Journal 2015;(2):186-188

8.Predictive effects of learning burnout on positive and negative mental health in college students

Kangjie QIAN ; Keli YIN ; Lirong ZHANG

Chinese Mental Health Journal 2015;(3):236-240

9.Relationship between polymorphism of N-acetyltransferase 2 gene and susceptibility to bladder cancer

Zhengkun YIN ; Dongkui SONG ; Lirong ZHANG

Chinese Journal of Urology 2001;0(04):-

10.Roles of Pericyte in the Angiogenesis of Endometriosis

Caiyun ZHAO ; Lirong YIN ; Junjie SUN

Tianjin Medical Journal 2014;(4):315-317,402

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 36 , 1/4 Show Home Prev Next End page: GO